443 related articles for article (PubMed ID: 16456095)
1. Effect of modified C-reactive protein on complement activation: a possible complement regulatory role of modified or monomeric C-reactive protein in atherosclerotic lesions.
Ji SR; Wu Y; Potempa LA; Liang YH; Zhao J
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):935-41. PubMed ID: 16456095
[TBL] [Abstract][Full Text] [Related]
2. Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q.
Jiang HX; Siegel JN; Gewurz H
J Immunol; 1991 Apr; 146(7):2324-30. PubMed ID: 2005402
[TBL] [Abstract][Full Text] [Related]
3. Monomeric C-reactive protein modulates classic complement activation on necrotic cells.
Mihlan M; Blom AM; Kupreishvili K; Lauer N; Stelzner K; Bergström F; Niessen HW; Zipfel PF
FASEB J; 2011 Dec; 25(12):4198-210. PubMed ID: 21856781
[TBL] [Abstract][Full Text] [Related]
4. Modified low density lipoproteins differentially bind and activate the C1 complex of complement.
Biró A; Thielens NM; Cervenák L; Prohászka Z; Füst G; Arlaud GJ
Mol Immunol; 2007 Feb; 44(6):1169-77. PubMed ID: 16938346
[TBL] [Abstract][Full Text] [Related]
5. Studies on the interactions between C-reactive protein and complement proteins.
Bíró A; Rovó Z; Papp D; Cervenak L; Varga L; Füst G; Thielens NM; Arlaud GJ; Prohászka Z
Immunology; 2007 May; 121(1):40-50. PubMed ID: 17244159
[TBL] [Abstract][Full Text] [Related]
6. Solid-phase classical complement activation by C-reactive protein (CRP) is inhibited by fluid-phase CRP-C1q interaction.
Sjöwall C; Wetterö J; Bengtsson T; Askendal A; Almroth G; Skogh T; Tengvall P
Biochem Biophys Res Commun; 2007 Jan; 352(1):251-8. PubMed ID: 17113035
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and functional characterization of the interaction between pentraxin 3 and C1q.
Nauta AJ; Bottazzi B; Mantovani A; Salvatori G; Kishore U; Schwaeble WJ; Gingras AR; Tzima S; Vivanco F; Egido J; Tijsma O; Hack EC; Daha MR; Roos A
Eur J Immunol; 2003 Feb; 33(2):465-73. PubMed ID: 12645945
[TBL] [Abstract][Full Text] [Related]
8. Interactions of C-reactive protein with low-density lipoproteins: implications for an active role of modified C-reactive protein in atherosclerosis.
Ji SR; Wu Y; Potempa LA; Qiu Q; Zhao J
Int J Biochem Cell Biol; 2006; 38(4):648-61. PubMed ID: 16376133
[TBL] [Abstract][Full Text] [Related]
9. Native and modified C-reactive protein bind different receptors on human neutrophils.
Heuertz RM; Schneider GP; Potempa LA; Webster RO
Int J Biochem Cell Biol; 2005 Feb; 37(2):320-35. PubMed ID: 15474978
[TBL] [Abstract][Full Text] [Related]
10. A redox switch in C-reactive protein modulates activation of endothelial cells.
Wang MY; Ji SR; Bai CJ; El Kebir D; Li HY; Shi JM; Zhu W; Costantino S; Zhou HH; Potempa LA; Zhao J; Filep JG; Wu Y
FASEB J; 2011 Sep; 25(9):3186-96. PubMed ID: 21670067
[TBL] [Abstract][Full Text] [Related]
11. Defined chemically cross-linked oligomers of human C-reactive protein: characterization and reactivity with the complement system.
Jiang H; Lint TF; Gewurz H
Immunology; 1991 Dec; 74(4):725-31. PubMed ID: 1783430
[TBL] [Abstract][Full Text] [Related]
12. Possible protective role for C-reactive protein in atherogenesis: complement activation by modified lipoproteins halts before detrimental terminal sequence.
Bhakdi S; Torzewski M; Paprotka K; Schmitt S; Barsoom H; Suriyaphol P; Han SR; Lackner KJ; Husmann M
Circulation; 2004 Apr; 109(15):1870-6. PubMed ID: 15037531
[TBL] [Abstract][Full Text] [Related]
13. Probing the C1q-binding site on human C-reactive protein by site-directed mutagenesis.
Agrawal A; Volanakis JE
J Immunol; 1994 Jun; 152(11):5404-10. PubMed ID: 8189060
[TBL] [Abstract][Full Text] [Related]
14. Monomeric CRP contributes to complement control in fluid phase and on cellular surfaces and increases phagocytosis by recruiting factor H.
Mihlan M; Stippa S; Józsi M; Zipfel PF
Cell Death Differ; 2009 Dec; 16(12):1630-40. PubMed ID: 19680263
[TBL] [Abstract][Full Text] [Related]
15. Activation of classical pathway of complement cascade by soluble oligomers of prion.
Dumestre-Pérard C; Osmundson J; Lemaire-Vieille C; Thielens N; Grives A; Favier B; Csopaki F; Jamin M; Gagnon J; Cesbron JY
Cell Microbiol; 2007 Dec; 9(12):2870-9. PubMed ID: 17991046
[TBL] [Abstract][Full Text] [Related]
16. Serum amyloid P component binds to histones and activates the classical complement pathway.
Hicks PS; Saunero-Nava L; Du Clos TW; Mold C
J Immunol; 1992 Dec; 149(11):3689-94. PubMed ID: 1431140
[TBL] [Abstract][Full Text] [Related]
17. Specific inhibition of the classical complement pathway with an engineered single-chain Fv to C1q globular heads decreases complement activation by apoptotic cells.
Duvall MR; Hwang HY; Boackle RJ
Immunobiology; 2010 May; 215(5):395-405. PubMed ID: 19586684
[TBL] [Abstract][Full Text] [Related]
18. Myeloperoxidase influences the complement regulatory function of modified C-reactive protein.
Xu PC; Li ZY; Yang XW; Zhao MH; Chen M
Innate Immun; 2014 May; 20(4):440-8. PubMed ID: 24189124
[TBL] [Abstract][Full Text] [Related]
19. Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques.
Eisenhardt SU; Habersberger J; Murphy A; Chen YC; Woollard KJ; Bassler N; Qian H; von Zur Muhlen C; Hagemeyer CE; Ahrens I; Chin-Dusting J; Bobik A; Peter K
Circ Res; 2009 Jul; 105(2):128-37. PubMed ID: 19520972
[TBL] [Abstract][Full Text] [Related]
20. beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain.
Jiang H; Burdick D; Glabe CG; Cotman CW; Tenner AJ
J Immunol; 1994 May; 152(10):5050-9. PubMed ID: 8176223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]